Artrya

Artrya uses artificial intelligence to deliver faster and more accurate diagnoses of Coronary Artery Disease. Left undiagnosed, patients remain at risk, incorrect treatment regimes are administered and cost burdens on health systems escalate. With ageing populations and the demand for medical services rising globally, significant delays in reporting can leave patients in critical situations.

Artrya headquartered in Australia, Oceania, operates in the Software, Biotechnology, Artificial Intelligence (AI), Machine Learning, Health Care, Medical, Health Diagnostics sector. The company focuses on Software and has secured $420.0M in funding across 28 round(s). With a team of 11-50 employees, Artrya is actively contributing to advancements in Software. Their latest funding round, Series A - Artrya, raised $15.0M. Discover more about their projects, partnerships, and impact on our platform.